Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice

Citations Over TimeTop 10% of 2016 papers

Abstract

Carbohydrate-based infusion solutions are widely used in the clinic. Here we show that co-administration of phosphorodiamidate morpholino oligomers (PMOs) with glucose enhances exon-skipping activity in Duchenne muscular dystrophy (DMD) mdx mice. We identify a glucose-fructose (GF) formulation that potentiates PMO activity, completely corrects aberrant Dmd transcripts, restores dystrophin levels in skeletal muscles and achieves functional rescue without detectable toxicity. This activity is attributed to enhancement of GF-mediated PMO uptake in the muscle. We demonstrate that PMO cellular uptake is energy dependent, and that ATP from GF metabolism contributes to enhanced cellular uptake of PMO in the muscle. Collectively, we show that GF potentiates PMO activity by replenishing cellular energy stores under energy-deficient conditions in mdx mice. Our findings provide mechanistic insight into hexose-mediated oligonucleotide delivery and have important implications for the development of DMD exon-skipping therapy.

Related Papers

• → Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs(2009)392 cited
• → Antisense Oligo-Mediated Multiple Exon Skipping in a Dog Model of Duchenne Muscular Dystrophy(2010)44 cited
• → In Vitro Assays to Assess Exon Skipping in Duchenne Muscular Dystrophy(2015)9 cited
• → Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy(2014)6 cited
• → 584. Myoblast Fusion Mediates Morpholino Entry and Exon Skipping In Dystrophic Muscle(2016)